首页> 外文会议>Asian Symposium on Biomedical Materials >Enzyme-Resistant Starch for Oral Colon-Targeting Drug Delivery System
【24h】

Enzyme-Resistant Starch for Oral Colon-Targeting Drug Delivery System

机译:用于口服结肠靶向药物递送系统的酶抗淀粉

获取原文

摘要

Colon-targeting drug delivery systems (CDDSs) are employed to improve the bioavailability of protein and peptide drugs through the oral route. So it is important to prepare the drug carriers for oral CDDS. In this study, the Enzyme-Resistant starch (RS) was studied for use as a vehicle in oral colon-targeting drug delivery. The characteristics of RS powders were investigated by X-ray diffraction, polarizing microscopy, DSC and SEM, and their film were examined by enzymatic digestion test. The results showed that RS could be a promising film-former for pharmaceutical coatings, having good stability to enzymatic digestion. Furthermore, a novel peroral formulation using RS coating and bovine serum albumin as a model drug was studied for colon-specific drug delivery in vitro. Drug release studies have shown that RS coating could delivery the drug to the colon and the release rate in simulated colonic fluids was dependent on the biodegradation of RS and its coatings. It is indicated that the RS coated tablet is a potential system for oral CDDS.
机译:使用结肠靶向药物递送系统(CDDS),用于通过口腔途径改善蛋白质和肽药物的生物利用度。因此,为口腔CDD制备药物载体是很重要的。在该研究中,研究了酶抗性淀粉(RS),用作口服结肠靶向药物递送的载体。通过X射线衍射研究了RS粉末的特性,通过酶消化试验检查了偏振显微镜,DSC和SEM,它们的薄膜检查。结果表明,RS可以是一种有前途的药物涂料,具有良好的酶消化稳定性。此外,研究了使用Rs涂层和牛血清白蛋白作为模型药物的新型运动制剂,用于在体外进行结肠特异性药物递送。药物释放研究表明,RS涂层可以将药物递送到结肠,模拟结肠液中的释放速率取决于Rs及其涂层的生物降解。表示RS涂层平板电脑是口服CDD的潜在系统。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号